Related Experiment Videos
Interleukin-16 network in inflammation and allergy
Pio Conti1, Duraisamy Kempuraj, Kristiana Kandere
1Immunology Division, University of Chieti, Via dei Vestini, Chieti, Italy.
Allergy and Asthma Proceedings
|May 11, 2002
Summary
Interleukin-16 (IL-16) does not impact mast cell activation or mediator release. Its primary role is chemoattraction of CD4+ T-cells, crucial for immune cell trafficking.
Area of Science:
- Immunology
- Cell Biology
- Cytokine Research
Background:
- Interleukin-16 (IL-16) is a cytokine known for its role as a T-cell-specific chemoattractant.
- IL-16 influences the trafficking of immune cells, particularly CD4+ T-cells.
- It has been implicated in modulating inflammatory mediators and other cytokines.
Purpose of the Study:
- To investigate the effect of IL-16 on human umbilical cord blood-derived mast cells.
- To determine if IL-16 influences mast cell mediator release (tryptase, IL-8) upon antigen challenge.
Main Methods:
- Cultured human umbilical cord blood-derived mast cells were used.
- Cells were treated with human recombinant IL-16 (0.2-200 ng/mL).
- Mast cells were stimulated with anti-immunoglobulin E (IgE) and challenged with antigen.
Main Results:
- IL-16 did not affect basal tryptase or IL-8 release from mast cells.
- IL-16 did not alter tryptase or IL-8 release induced by anti-IgE activation.
- The study did not find IL-16 to be a significant modulator of mast cell mediator release.
Conclusions:
- The primary function of IL-16 remains the chemoattraction of CD4+ cells.
- IL-16 does not appear to play a significant role in mast cell activation or mediator release.
- Further research supports IL-16's established role in immune cell trafficking.